<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Th1/Th2 Cytokines in Patients with Graves' Disease with or without Ophthalmopathy</title>
    <FirstPage>168</FirstPage>
    <LastPage>175</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Fatemeh</FirstName>
        <LastName>Esfahanian</LastName>
        <affiliation locale="en_US">Department of Endocrinology, Imam Khomeini Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Effat</FirstName>
        <LastName>Naimi</LastName>
        <affiliation locale="en_US">Department of Endocrinology, Baqiyatallah University of Medical sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Farideh</FirstName>
        <LastName>Doroodgar</LastName>
        <affiliation locale="en_US">Eye Research Center, Imam Khomeini Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zohre</FirstName>
        <LastName>Jadali</LastName>
        <affiliation locale="en_US">Department of Pathobiology, Immunology Division, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">About 25-50% of Graves' disease (GD) patients develop thyroid eye diseases, which is associated with inflammatory process and abnormalities in the levels of several cytokines in orbital tissues in GD.&#xA0; The aim of this study was to determine the Th1 and Th2 serum cytokines in patients with GD with or without ophthalmopathy.
Serum&#xA0; levels of&#xA0; cytokines&#xA0; and&#xA0; autoantibodies&#xA0; including Interferon-gamma&#xA0; (IFN-&#x3B3;),Interleukin-2 (IL-2), Interleukin-4 (IL-4), Interleukin-10 (IL-10), TSH receptor autoantibody (TRAb), thyroid&#xA0; peroxidase antibody (TPOAb)&#xA0; and&#xA0; thyroglobulin antibody(TgAb) were measured by enzyme linked immunosorbent assay(ELISA) in 34 patients with GD and in 33 normal controls. Patients were also divided in two subgroups: 18 cases with ophthalmopathy and 16 cases without ophthalmopathy. Cytokine and antibody responses were analyzed in both groups.
Compared with control subjects, patients with GD&#xA0; showed elevated levels of IL-2 and IL-10. IFN-&#x3B3;&#xA0; levels were lower in patients in comparison to the controls. No significant differences were found&#xA0; between patients and controls regarding the IL-4. There was no statistically significant&#xA0; difference&#xA0; in&#xA0; cytokine&#xA0; levels&#xA0; between&#xA0; those&#xA0;&#xA0; with&#xA0; or&#xA0;&#xA0; without ophthalmopathy.
Quantitative-cytokine&#xA0; analysis&#xA0; demonstrated&#xA0; that&#xA0; a&#xA0; combination&#xA0; of&#xA0; Th1&#xA0; and&#xA0; Th2 cytokines may contribute to the pathogenesis of GD. These results also indicate that IL-10, but not IL-4, is related to the moderate and severe forms of thyroid associated ophthalmophathy.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/517</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/517/515</pdf_url>
  </Article>
</Articles>
